GOLDEN ARTHUR F 4
4 · Turn Therapeutics Inc. · Filed Oct 23, 2025
Insider Transaction Report
Form 4
GOLDEN ARTHUR F
Director
Transactions
- Purchase
Common Stock
2025-10-23$4.95/sh+20,202$100,000→ 30,202 total
Footnotes (1)
- [F1]Certain of the securities reported in Column 5 of Table I are restricted stock units ("RSUs") granted under the Issuer's 2025 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock, subject to the applicable vesting schedule and the reporting person's continuous service through the vesting date.